Kura Oncology KURA
$6.91 −$0.44 (-5.99%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.94 +0.43%
Open$7.13
Prev close$7.35
Day range$6.89 – $7.37
Volume1.75M
Market cap$634.88M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$22.84M+10.1% YoY
Operating profit-$74.66M+6.7% YoY
Net profit-$70.22M+5.3% YoY
Diluted EPS-$0.78+8.2% YoY
Free cash flow-$54.89M+34.0% YoY
Operating cash flow-$54.44M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin98.8%
Operating margin-394.3%
Net margin-369.3%
Return on equity-224.9%
Return on assets-48.2%
Return on invested capital-199.4%
Current ratio3.60
Liabilities / assets96.8%
Cash & investments$492.10M
Total debt$23.95M
Net cash (debt)$468.14M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $22.84M | $20.87M | $18.27M | $67.48M | $17.34M |
| Total Operating Revenue | $22.84M | $20.87M | $18.27M | $67.48M | $17.34M |
| Cost of Revenue | $371,000.00 | $243,000.00 | $262,000.00 | $57,000.00 | $57,000.00 |
| Gross Profit | $22.47M | $20.63M | $18.00M | $67.43M | $17.28M |
| Operating Expense | $97.13M | $93.64M | $96.82M | $371.06M | $103.55M |
| Selling and Admin Expenses | $30.25M | $31.75M | $31.56M | $119.98M | $39.14M |
| -General & Admin Expense | $30.25M | $31.75M | $31.56M | $119.98M | $39.14M |
| Research & Development | $66.88M | $61.89M | $65.26M | $251.07M | $64.41M |
| Operating Profit | -$74.66M | -$73.01M | -$78.82M | -$303.63M | -$86.27M |
| Net Non-Operating Interest Income (Expense) | $4.44M | $4.69M | $5.49M | $25.26M | $5.34M |
| Non-Operating Interest Income | $4.79M | $5.03M | $5.83M | $26.77M | $5.69M |
| Non-Operating Interest Expense | $350,000.00 | $345,000.00 | $336,000.00 | $1.51M | $346,000.00 |
| Earnings from Equity Interest | -$30.59M | – | – | – | – |
| Special Income (Charges) | $30.59M | – | – | – | – |
| -Gain on Sale Of Business | $30.59M | – | – | – | – |
| Pretax Profit | -$70.22M | -$68.32M | -$73.33M | -$278.37M | -$80.93M |
| Tax | $0.00 | $5,000.00 | $8,000.00 | $297,000.00 | $71,000.00 |
| Net Profit | -$70.22M | -$68.33M | -$73.33M | -$278.67M | -$81.00M |
| Profit from Continuing Operations | -$70.22M | -$68.33M | -$73.33M | -$278.67M | -$81.00M |
| Net Income to Parent Company | -$70.22M | -$68.33M | -$73.33M | -$278.67M | -$81.00M |
| Net Income to Common Stockholders | -$70.22M | -$68.33M | -$73.33M | -$278.67M | -$81.00M |
| Basic EPS | -$0.78 | -$0.77 | -$0.83 | -$3.18 | -$0.92 |
| Diluted EPS | -$0.78 | -$0.77 | -$0.83 | -$3.18 | -$0.92 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $566.50M | $587.79M | $652.55M | $738.36M | $738.36M |
| Total Current Assets | $534.70M | $559.44M | $623.78M | $708.66M | $708.66M |
| Cash and Cash Equivalents & Short-Term Investments | $492.10M | $519.03M | $580.82M | $667.24M | $667.24M |
| -Cash and Cash Equivalents | $57.94M | $70.24M | $39.08M | $149.10M | $149.10M |
| -Short Term Investments | $434.16M | $448.78M | $541.74M | $518.14M | $518.14M |
| Receivables | $14.49M | $9.45M | $9.35M | $8.80M | $8.80M |
| -Accounts Receivable | $14.49M | $9.45M | $9.35M | $8.80M | $8.80M |
| Inventory | $4.98M | $2.49M | $843,000.00 | $413,000.00 | $413,000.00 |
| Other Current Assets | $23.13M | $28.48M | $32.77M | $32.21M | $32.21M |
| Total Non-Current Assets | $31.80M | $28.35M | $28.77M | $29.70M | $29.70M |
| Net PPE | $14.37M | $14.62M | $14.78M | $15.16M | $15.16M |
| -Gross PPE | $18.31M | $18.23M | $18.02M | $18.06M | $18.06M |
| -Accumulated Depreciation | -$3.94M | -$3.61M | -$3.24M | -$2.90M | -$2.90M |
| Other Non-Current Assets | $17.43M | $13.73M | $13.99M | $14.54M | $14.54M |
| Total Liabilities | $548.54M | $539.36M | $544.67M | $564.23M | $564.23M |
| Total Current Liabilities | $148.73M | $118.19M | $101.50M | $116.97M | $116.97M |
| Payables | $8.13M | $2.45M | $7.28M | $5.26M | $5.26M |
| -Accounts Payable | $8.13M | $2.39M | $7.04M | $5.02M | $5.02M |
| Current Accrued Expenses | $48.29M | $40.41M | $34.76M | $39.09M | $39.09M |
| Short-Term Debt and Capital Lease Obligation | $10.41M | $5.51M | $1.28M | $1.28M | $1.28M |
| -Current Debt | $8.53M | $4.22M | – | – | – |
| -Current Capital Lease Obligation | $1.88M | $1.29M | $1.28M | $1.28M | $1.28M |
| Current Deferred Liabilities | $63.49M | $55.48M | $47.70M | $48.98M | $48.98M |
| Total Non-Current Liabilities | $399.81M | $421.17M | $443.17M | $447.25M | $447.25M |
| Long Term Debt and Capital Lease Obligation | $15.42M | $18.95M | $22.99M | $19.18M | $19.18M |
| -Long Term Debt | $1.30M | $5.57M | $9.75M | $9.71M | $9.71M |
| -Long Term Capital Lease Obligation | $14.12M | $13.37M | $13.24M | $9.47M | $9.47M |
| Non-Current Deferred Liabilities | $380.40M | $398.60M | $416.75M | $424.91M | $424.91M |
| Other Non-Current Liabilities | $3.98M | $3.62M | $3.44M | $3.17M | $3.17M |
| Total Equity | $17.96M | $48.43M | $107.88M | $174.14M | $174.14M |
| Stockholders' Equity | $17.96M | $48.43M | $107.88M | $174.14M | $174.14M |
| Capital Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Common Stock | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 | $9,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.41B | $1.37B | $1.36B | $1.35B | $1.35B |
| Retained Earnings | -$1.39B | -$1.32B | -$1.25B | -$1.17B | -$1.17B |
| Gains/Losses Not Affecting Retained Earnings | -$2.18M | -$1.21M | -$380,000.00 | $1.02M | $1.02M |
| -Total Tax Payable | – | $59,000.00 | $239,000.00 | $239,000.00 | $239,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$54.44M | -$62.55M | -$85.85M | -$64.06M | $117.27M |
| Net cash flow from continuing operations | -$54.44M | -$62.55M | -$85.85M | -$64.06M | $117.27M |
| Net Income from Continuing Operations | -$70.22M | -$68.33M | -$73.33M | -$278.67M | -$81.00M |
| Depreciation & Depletion & Amortization | $329,000.00 | $369,000.00 | $355,000.00 | $1.03M | $403,000.00 |
| Other Non-Cash Items | $117,000.00 | $111,000.00 | $106,000.00 | $515,000.00 | $103,000.00 |
| Change in Working Capital | $7.79M | -$2.17M | -$20.50M | $184.44M | $187.80M |
| -Change in Receivables | -$5.04M | -$98,000.00 | -$544,000.00 | -$6.74M | $27.13M |
| -Change in Inventory | -$2.50M | -$1.64M | -$430,000.00 | -$413,000.00 | -$413,000.00 |
| -Change in Prepaid Assets | $5.49M | $4.34M | -$562,000.00 | -$15.95M | $2.89M |
| -Change in Payables and Accrued Expense | $17.87M | $5.01M | -$14.19M | $17.15M | $2.35M |
| -Change in Other Current Assets | $536,000.00 | $336,000.00 | $689,000.00 | -$6.36M | -$558,000.00 |
| -Change in Other Current Liabilities | $1.62M | $250,000.00 | $3.98M | $1.04M | $112,000.00 |
| -Change In Other Working Capital | -$10.19M | -$10.36M | -$9.44M | $195.72M | $156.29M |
| Net cash flow from investing | $9.60M | $92.21M | -$24.23M | -$13.10M | -$64.60M |
| Net Cash Flow from Continuing Investing Activities | $9.60M | $92.21M | -$24.23M | -$13.10M | -$64.60M |
| Net PPE Purchase and Sale | -$445,000.00 | -$656,000.00 | -$128,000.00 | -$6.64M | -$2.32M |
| Net Investment Purchase and Sale | $10.04M | $92.87M | -$24.10M | -$6.46M | -$62.28M |
| Financing Cash Flow | $32.54M | $1.50M | $69,000.00 | $1.79M | $1.14M |
| Net Cash Flow from Continuing Financing Activities | $32.54M | $1.50M | $69,000.00 | $1.79M | $1.14M |
| Proceeds from Stock Option Exercised | $1.01M | $1.50M | $69,000.00 | $1.79M | $1.14M |
| Ending Cash Balance | $57.94M | $70.24M | $39.08M | $149.10M | $149.10M |
| Net Change in Cash | -$12.31M | $31.16M | -$110.02M | -$75.36M | $53.81M |
| Beginning Cash Balance | $70.24M | $39.08M | $149.10M | $224.46M | $95.29M |
| Free Cash Flow | -$54.89M | -$63.21M | -$85.98M | -$70.70M | $114.95M |
| Net Common Stock Issuance | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on KURA.
Sign in to join the discussion.